Potentiation and mechanism of cisplatin-induced apoptosis by lidamycin in human hepatoma BEL-7402 cells

Yaoxue Xuebao

Volumn 38, Issue 4, 2003, Pages 250-254

  Liu, Hong Zun ^a   Li, Dian Dong ^a   Zhen, Yong Su ^a   Shao, Rong Guang ^a  

^a INSTITUTE OF MEDICINAL BIOTECHNOLOGY   (China)

Author keywords

Apoptosis; Cisplatin; Hepatoma cells; Lidamycin; Synergetic effect

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC C 1027; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; CISPLATIN; ENEDIYNE; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE S PHASE; DRUG EFFECT; DRUG POTENTIATION; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PATHOLOGY;

AMINOGLYCOSIDES; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CISPLATIN; DRUG SYNERGISM; ENEDIYNES; HUMANS; LIVER NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; S PHASE; TUMOR CELLS, CULTURED;

EID: 2142691204     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Hu JL, Xue YC, Xie M Y, et al. A new macromolecular antitumor antibiotic, C-1027. I. Discovery, taxonomy of producing organism fermentation and biological activity [J]. J Antibiot, 1988,41(11):1575-1579.
2. Otani T, Minami Y, Marunaka T, et al. A new macromolecular antitumor antibiotic, C1027. II. Isolation and physico-chemical properties [J]. J Antibiot, 1988,41(11):1580-1585.
3. Zhen YS, Ming XY, Yu B, et al. A new macromolecular antitumor antibiotic, C-1027. III. Antitumor Activity [J]. J Antibiot, 1989,42(8):1294-1298.
4. Cao SS, Zhen YS. Potentiation of antimetabolite antitumor activity in vivo by dipyridamole and amphotericin B [J]. Cancer Chemother Pharmacol, 1989,24(3):181-186.
5. Takahashi M, Kataoka S, Kobayashi E, et al. Differences in apoptosis induced by anticancer drugs in sublines (SKG-3a, SKG-3b) from a human uterine cervical epidermoid carcinoma [J]. Oncol Res, 1999,11(2):71-75.
6. Han R. Research and Experiment Technology of Antitumor Drugs [M]. Beijing: Peking Union Medical College and Beijing Medical University Press, 1997.396-397.
7. Jing M, Wenlie P, Dong L, et al. The extract of glycyrrhiza uralensis fisch induces apoptotis in MGC-803 cells and its molecular mechanism [J]. Biomed Res, 2000,21(3):129-137.
8. Jin DY, Li MF. Molecular Clone: A Laboratory Manual [M]. Beijing: Science Press, 1992.888-898.
9. Otani T, Yasuhara T. Purification and primary structure of C-1027 AG, a selective antagonist of antitumor antibiotic C1027 from Streptomyccs globisporus [J]. Agric Biol Chem, 1991,55(2):407-417.
10. Jiang B, Li DD, Zhen YS. Induction of apoptosis by enediyne antitumor antibiotic C-1027 in HL-60 human promyclocytie leukemia cells [J]. Biochem Biophys Res Commun, 1995,208(1):238-244.
11. Zhen HY, Xue YC, Zhen YS. Inhibition of angiogenesis by antitumor antibiotic C1027 and its effect on tumor metastasis [J]. Natl Med J Chinai , 1997,77(9):657-660.
12. Shao RG, Zhen YS. Antitumor activity of new antitumor antibiotic C1027 and its monoclonal antibody assembled conjugate [J]. Acta Pharm Sin , 1992,27(7):486-491.
13. Gasparini G. Metronomic scheduling: the future of chemotherapy [J]. Lancet Oncol, 2001,2(12):733-740.